Literature DB >> 7789013

Infective endocarditis in neonates.

A H Daher1, F E Berkowitz.   

Abstract

We studied retrospectively the predisposing factors and signs of infective endocarditis (IE) in neonates and infants younger than 3 months of age, and we suggest diagnostic criteria. The charts of 16 infants less than 3 months of age, diagnosed with IE during a 5-year period, were reviewed for possible maternal and infant risk factors and for pathognomonic clinical and laboratory features. No apparent maternal risk factors were noted. Infant risk factors were congenital heart disease (4), patent ductus arteriosus (PDA) (5), and the use of central venous catheters (14). The main clinical findings were cardiac murmurs (12), petechiae (2), skin abscesses (7), arthritis (2), hepatomegaly (9), and splenomegaly (2). Echocardiography revealed a mass or vegetation in nine patients. Of the 27 microorganisms isolated from blood, the most common were staphylococci (15) and Candida sp. (6). Urine cultures were positive in six patients and cerebrospinal fluid cultures were positive in one. Other laboratory findings were not of diagnostic value. We conclude that the main risk factors for neonatal IE are central venous catheters and congenital heart disease, including PDA. The main causative microorganisms are staphylococci and Candida sp. The main investigations of diagnostic value are blood and urine cultures and echocardiography. We propose the diagnostic categories of definite, probable, and possible cases of neonatal IE, based primarily on clinical, blood culture, and echocardiographic data.

Entities:  

Mesh:

Year:  1995        PMID: 7789013     DOI: 10.1177/000992289503400405

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  9 in total

1.  Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth.

Authors:  Mohan Pammi Venkatesh; Don Pham; Mindy Fein; Lingkun Kong; Leonard E Weisman
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

Review 2.  Infective endocarditis in congenital heart disease.

Authors:  Walter Knirsch; David Nadal
Journal:  Eur J Pediatr       Date:  2011-07-20       Impact factor: 3.183

3.  Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-γ produced in part by iNKT cells.

Authors:  Norihito Tarumoto; Yuki Kinjo; Naoki Kitano; Daisuke Sasai; Keigo Ueno; Akiko Okawara; Yuina Izawa; Minoru Shinozaki; Hiroshi Watarai; Masaru Taniguchi; Haruko Takeyama; Shigefumi Maesaki; Kazutoshi Shibuya; Yoshitsugu Miyazaki
Journal:  J Infect Dis       Date:  2013-10-04       Impact factor: 5.226

4.  Pediatric infective endocarditis: Has Staphylococcus aureus overtaken viridans group streptococci as the predominant etiological agent?

Authors:  Aisha Alshammary; Marilou Hervas-Malo; Joan L Robinson
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

Review 5.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Culture-negative neonatal meningitis and endocarditis caused by Streptococcus agalactiae.

Authors:  Valérie Lefranc Nègre; Anne-Marie Colin-Gorski; Suzel Magnier; Lydia Maisonneuve; Yannick Aujard; Edouard Bingen; Stéphane Bonacorsi
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 7.  Fungal endocarditis in neonates and children.

Authors:  B C Millar; J Jugo; J E Moore
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

8.  Changing Risk Factors for Pediatric Infective Endocarditis.

Authors:  Margaret C. Fisher
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.663

9.  Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study.

Authors:  Mohan Pammi; Danni Zhong; Yvette Johnson; Paula Revell; James Versalovic
Journal:  BMC Infect Dis       Date:  2014-07-14       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.